Cláudia Vaz de Melo Sette

Integrating ChatGPT into Real-Time Multidisciplinary Oncology Discussions

Beatriz Favero Perez, Jean Marcelo Strippoli Doffini, Fábio de Azevedo Gonçalves, Cláudia Vaz de Melo Sette et autres

br (code pays fourni par la source)

Impact of the Charlson Comorbidity Index on Overall Survival in Cancer Patients Aged ≥ 80: A Retrospective Analysis in a Brazilian Public Hospital

Gustavo Henrique Barboza Nascimento, Daniele Evaristo Vieira Alves, Auro del Giglio, Daniel de Iracema Gomes Cubero et autres

br (code pays fourni par la source)

Palliative Care in Cancer Patients Aged 80 Years and Older: Clinical Profile and Survival Analysis

Gustavo Henrique Barboza Nascimento, Daniele Evaristo Vieira Alves, Auro del Giglio, Daniel de Iracema Gomes Cubero et autres

br (code pays fourni par la source)

Clinical and epidemiological profile and overall survival by age-adjusted Charlson Comorbidity Index in patients aged 80 years or older receiving cancer care in São Paulo, Brazil.

Gustavo Nascimento, Daniele Evaristo Vieira Alves, Auro del Giglio, Daniel de Iracema Gomes Cubero et autres

br (code pays fourni par la source)

89P Real-time integration of ChatGPT into multidisciplinary tumor boards: A prospective study in general medical oncology

Berenice Pérez, J. Doffini, F. Gonçalves, Cláudia Vaz de Melo Sette et autres

br (code pays fourni par la source)

P1.17.82 Lung Cancer’s Price Tag: Escalating Hospitalization Costs in Brazil Over the Past Two Decades

André de Paula Viana, Marcos Magalhães Filho, J. Favoretto Neto, Luiz Vinicius de Alcantara Sousa Alcantara Sousa et autres

br (code pays fourni par la source)

Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study

Shun Lü, О. І. Vynnychenko, Yaroslav Kulyaba, Vladimer Kuchava et autres

cn, ua, my, ru, tr, vn, rs, ge, us, br (code pays fourni par la source)

Melanoma mortality in Brazil: Insights from over 25 years of data and the impact of limited immunotherapy access in the public health system.

Clarisse Kaori Fujishige, Luiz Vinícius de Alcantara Sousa, Cláudia Vaz de Melo Sette, Patrícia Xavier Santi et autres

br (code pays fourni par la source)

Does inequality affect prostate cancer? Time trend of prostate cancer mortality and association with gini index in Brazil

Juliana G. Xande, Jean Henri Maselli-Schoueri, Cláudia Vaz de Melo Sette, Juliana Vieira Biason Bonometto et autres

OC.04.3 RNA-SEQUENCING ON EUS-ACQUIRED TISSUE OF PANCREATIC CANCER IS FEASIBLE AND ALLOWS IDENTIFICATION OF BIOMARKERS OF PROGNOSIS AND OF RESPONSE TO INTENSIFIED CHEMOTHERAPY

L. Archibugi, C Fortunato, P. Lazzano, Ruggero Ponz de Leon Pisani et autres

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Robert I. Haddad, Jérôme Fayette, Maria Teixeira, Kumar Prabhash et autres

us, fr, pt, in, es, th, cn, jp, tw, it, br, gb (code pays fourni par la source)

How are we allocating physicians to deal with breast cancer in men and women in Brazil?

Jean Henri Maselli-Schoueri, Luis Eduardo Werneck De Carvalho, Cláudia Vaz de Melo Sette, Luíz Carlos de Abreu et autres

br, ie (code pays fourni par la source)